Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses

99mTc-sestamibi SPECT/CT for the diagnosis of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors: Combined data from prospective trials and real-world clinical experience

(2019) A.R. Meyer et al.   EUROPEAN UROLOGY SUPPLEMENTS

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

(2019) Börje Ljungberg et al.   EUROPEAN UROLOGY

The role of molecular imaging in the characterization of renal masses

(2018) Alexa R. Meyer et al.   CURRENT OPINION IN UROLOGY

The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment

(2018) Bimal Bhindi et al.   EUROPEAN UROLOGY

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

(2018) Robert J. Motzer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of 99m Tc-sestamibi Single-photon Emission Computed Tomography / X-ray Computed Tomography in the Diagnosis of Hybrid Oncocytic / Chromophobe Tumor in a Pediatric Patient

(2018) Nima Almassi et al.   UROLOGY

Renal Mass and Localized Renal Cancer: AUA Guideline

(2017) Steven Campbell et al.   JOURNAL OF UROLOGY

Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of 99mTc-MIBI SPECT/CT

(2017) Andrew M. Reynolds et al.   Current Urology Reports

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT

(2017) Antonios Tzortzakakis et al.   EJNMMI Research

Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?

(2017) Steven P. Rowe et al.   EJNMMI Research

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

(2017) Steven P. Rowe et al.   EJNMMI Research

Prospective Evaluation of 99mTc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors

(2016) Michael A. Gorin et al.   EUROPEAN UROLOGY

Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature

(2016) Hiten D. Patel et al.   JOURNAL OF UROLOGY

Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma

(2015) Steven P. Rowe et al.   CLINICAL NUCLEAR MEDICINE

Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate

(2015) David C. Johnson et al.   JOURNAL OF UROLOGY

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease

(2013) Zachary Klinghoffer et al.   CUAJ-Canadian Urological Association Journal

Cost-Effectiveness Analysis of Nephron Sparing Options for the Management of Small Renal Masses

(2011) Steven L. Chang et al.   JOURNAL OF UROLOGY

The Cost-Effectiveness of Immediate Treatment, Percutaneous Biopsy and Active Surveillance for the Diagnosis of the Small Solid Renal Mass: Evidence From a Markov Model

(2011) Marta E. Heilbrun et al.   JOURNAL OF UROLOGY

Renal Mass Biopsy to Guide Treatment Decisions for Small Incidental Renal Tumors: A Cost-effectiveness Analysis

(2010) Pari V. Pandharipande et al.   RADIOLOGY